Robert Andtbacka

I am thrilled to join the #HiFiBiO team as Chief Medical Officer. I am deeply impressed by HiFiBiO’s innovative approach to developing novel #immune therapies. Together we will advance groundbreaking therapies, providing improved disease treatments and renewed hope for #patients.

@7and8biopharma reaches a new clinical development milestone for BDB001 monotherapy: First Patient Treated in a Phase 2 Clinical Trial in anti-PD-1 / anti-PD-L1 Refractory Solid Tumors. Full Release: 7and8biopharma.com/seven-and-eigh… #immunotherapy #cancer #oncology #TLR78 #BDB001

We are happy to announce an abstract detailing interim data for BDB001 in combination with pembrolizumab was accepted for a poster discussion presentation at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting. 7and8biopharma.com/seven-and-eigh…

Just released New Response Criteria for Intratumoral Immunotherapy in Solid Tumors: itRECIST ascopubs.org/doi/full/10.12…. @greg_goldmacher @AnuradhaK_MD @jasonlukemd ⁦@dcmadoff⁩ #itRECIST #oncology #intratumoral #Immunotherapy ascopubs.org/doi/full/10.12…

Seven and Eight Biopharmaceuticals Inc. reaches important milestone with clinical collaboration with Merck (MSD). The safety and anti tumor activity of BDB001, a novel TLR 7/8 agonist, will be studied in combo with pembrolizumab in pts with solid tumors.businesswire.com/news/home/2019…

Fantastic meeting in Iaşi Romania #updatesinoncology

T-VEC approved for metastatic melanoma. A good day for patients fda.gov/NewsEvents/New…

Welcome to Huntsman Immunotherapy conference on Saturday. huntsmancancer.org/immunotherapy2…

Thanks presenters @RobertAndtbacka, Carvajal @columbiacancer, Hoffner,Postow @MSKCC_OncoNotes , Faries @JohnWayneCI

@OmidHamidMD @Amgen yes Omid, it never stops. #lovethepatientsacceptthehours

All about #TVEC and @Amgen desire to get #oncolytic therapy approved seekingalpha.com/pr/13308416-am…

FDA Panels Support Approval of T-VEC in Melanoma $amgn shar.es/1pxi5L via @OncLive | this is great news for IT immunotherapy! $oncs

Exciting news about Cavatak presented at AACR. viralytics.com/wp-content/upl…